IL285914B2 - Norovirus-like particles with improved stability - Google Patents
Norovirus-like particles with improved stabilityInfo
- Publication number
- IL285914B2 IL285914B2 IL285914A IL28591421A IL285914B2 IL 285914 B2 IL285914 B2 IL 285914B2 IL 285914 A IL285914 A IL 285914A IL 28591421 A IL28591421 A IL 28591421A IL 285914 B2 IL285914 B2 IL 285914B2
- Authority
- IL
- Israel
- Prior art keywords
- amino acid
- seq
- protein
- acid sequence
- genogroup
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19162266 | 2019-03-12 | ||
| PCT/EP2020/056461 WO2020182860A1 (en) | 2019-03-12 | 2020-03-11 | Norovirus-like particles with improved stability |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL285914A IL285914A (en) | 2021-10-31 |
| IL285914B1 IL285914B1 (en) | 2024-07-01 |
| IL285914B2 true IL285914B2 (en) | 2024-11-01 |
Family
ID=65818179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL285914A IL285914B2 (en) | 2019-03-12 | 2020-03-11 | Norovirus-like particles with improved stability |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220152186A1 (https=) |
| EP (1) | EP3938378B1 (https=) |
| JP (2) | JP7536031B2 (https=) |
| KR (1) | KR20220021451A (https=) |
| CN (1) | CN113557240B (https=) |
| AU (1) | AU2020235344B2 (https=) |
| ES (1) | ES2953232T3 (https=) |
| IL (1) | IL285914B2 (https=) |
| MX (1) | MX2021011059A (https=) |
| WO (1) | WO2020182860A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020235344B2 (en) * | 2019-03-12 | 2024-10-24 | Icon Genetics Gmbh | Norovirus-like particles with improved stability |
| US20250002539A1 (en) * | 2021-07-26 | 2025-01-02 | The University Of North Carolina At Chapel Hill | Methods and compositions for norovirus chimeric therapeutics |
| CN118252924A (zh) * | 2022-12-27 | 2024-06-28 | 远大赛威信生命科学(南京)有限公司 | 用于诱发哺乳动物针对诺如病毒的免疫反应的药物组合物及其制备方法和用途 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1025234A1 (en) | 1997-10-24 | 2000-08-09 | E.I. Du Pont De Nemours And Company | Binary viral expression system in plants |
| EP1115870A2 (en) | 1998-09-23 | 2001-07-18 | E.I. Du Pont De Nemours And Company | Binary viral expression system in plants |
| DE10109354A1 (de) | 2001-02-27 | 2002-09-05 | Icon Genetics Ag | Rekombinante virale Schaltersysteme |
| DE10121283B4 (de) | 2001-04-30 | 2011-08-11 | Icon Genetics GmbH, 80333 | Verfahren und Vektoren zur Amplifikation oder Expression von gewünschten Nucleinsäuresequenzen in Pflanzen |
| CN1533438A (zh) | 2001-06-08 | 2004-09-29 | �����Ŵ��Ƽ���˾ | 在植物生产蛋白质的方法 |
| AU2002314021B2 (en) | 2002-04-30 | 2008-04-10 | Icon Genetics Gmbh | Amplification vectors based on trans-splicing |
| WO2006012906A1 (en) | 2003-11-10 | 2006-02-09 | Icon Genetics Ag | Rna virus-derived plant expression system |
| ATE469231T1 (de) | 2003-11-10 | 2010-06-15 | Icon Genetics Gmbh | Von rna-virus abgeleitetes pflanzenexpressionssystem |
| EP1564295A1 (en) | 2004-01-23 | 2005-08-17 | Icon Genetics AG | RNA virus-derived plant expression system |
| EP1616959A1 (en) | 2004-07-07 | 2006-01-18 | Icon Genetics AG | Biological safe transient protein expression in plants |
| CA2648886C (en) | 2006-05-29 | 2015-10-20 | Icon Genetics Gmbh | Plant virus-based inducible expression system |
| EP1897953A1 (en) | 2006-09-06 | 2008-03-12 | Icon Genetics GmbH | Potexvirus-derived replicon |
| SG10202012986SA (en) | 2006-09-29 | 2021-01-28 | Ligocyte Pharmaceuticals Inc | Norovirus vaccine formulations |
| JP5846908B2 (ja) * | 2009-05-28 | 2016-01-20 | 東洋紡株式会社 | 特性の改変されたグルコースデヒドロゲナーゼ |
| AU2011276328C1 (en) * | 2010-07-06 | 2016-01-21 | Novartis Ag | Norovirus derived immunogenic compositions and methods |
| EP2418283A1 (en) | 2010-08-07 | 2012-02-15 | Nomad Bioscience GmbH | Process of transfecting plants |
| EP2647715A1 (en) | 2012-04-03 | 2013-10-09 | Nomad Bioscience GmbH | Agrobacterium for transient transfection of whole plants |
| JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
| CA2913068C (en) | 2013-05-23 | 2023-01-10 | Nomad Bioscience Gmbh | Process of providing plants with abiotic stress resistance |
| US11208441B2 (en) * | 2015-10-22 | 2021-12-28 | Protenova Co., Ltd. | Immunoglobulin-binding polypeptide |
| EP3601580A4 (en) * | 2017-03-23 | 2021-01-06 | Medicago Inc. | NOROVIRUS FUSION PROTEINS AND VLPS WITH NOROVIRUS FUSION PROTEINS |
| AU2020235344B2 (en) * | 2019-03-12 | 2024-10-24 | Icon Genetics Gmbh | Norovirus-like particles with improved stability |
-
2020
- 2020-03-11 AU AU2020235344A patent/AU2020235344B2/en active Active
- 2020-03-11 KR KR1020217032648A patent/KR20220021451A/ko not_active Ceased
- 2020-03-11 ES ES20708137T patent/ES2953232T3/es active Active
- 2020-03-11 US US17/438,047 patent/US20220152186A1/en active Pending
- 2020-03-11 CN CN202080020212.XA patent/CN113557240B/zh active Active
- 2020-03-11 MX MX2021011059A patent/MX2021011059A/es unknown
- 2020-03-11 IL IL285914A patent/IL285914B2/en unknown
- 2020-03-11 JP JP2021552611A patent/JP7536031B2/ja active Active
- 2020-03-11 WO PCT/EP2020/056461 patent/WO2020182860A1/en not_active Ceased
- 2020-03-11 EP EP20708137.3A patent/EP3938378B1/en active Active
-
2023
- 2023-09-13 JP JP2023148763A patent/JP7672460B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3938378A1 (en) | 2022-01-19 |
| EP3938378C0 (en) | 2023-08-02 |
| IL285914A (en) | 2021-10-31 |
| JP2022522891A (ja) | 2022-04-20 |
| CN113557240B (zh) | 2025-02-25 |
| MX2021011059A (es) | 2021-10-13 |
| CA3133030A1 (en) | 2020-09-17 |
| AU2020235344A1 (en) | 2021-09-23 |
| JP7672460B2 (ja) | 2025-05-07 |
| EP3938378B1 (en) | 2023-08-02 |
| JP7536031B2 (ja) | 2024-08-19 |
| WO2020182860A1 (en) | 2020-09-17 |
| IL285914B1 (en) | 2024-07-01 |
| JP2024009801A (ja) | 2024-01-23 |
| US20220152186A1 (en) | 2022-05-19 |
| CN113557240A (zh) | 2021-10-26 |
| KR20220021451A (ko) | 2022-02-22 |
| AU2020235344B2 (en) | 2024-10-24 |
| ES2953232T3 (es) | 2023-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7672460B2 (ja) | 安定性が改善されたノロウイルス様粒子 | |
| US12076388B2 (en) | Modified norovirus VP1 proteins and VLPS comprising modified norovirus VP1 proteins | |
| CA2814175C (en) | Norovirus capsid and rotavirus vp6 protein for use as combined vaccine | |
| US20230256078A1 (en) | Immunogenic composition and vaccine for generating an immune response to norovirus | |
| US7413889B2 (en) | Production of a parvovirus vaccine in plants as viral coat protein fusions | |
| EP3882351A1 (en) | Recombinant vector for expressing virus-like particles in plant and method for preparation of vaccine composition containing circovirus-like particles by using same | |
| Gil et al. | Successful oral prime‐immunization with VP60 from rabbit haemorrhagic disease virus produced in transgenic plants using different fusion strategies | |
| CN112135630A (zh) | 猪瘟疫苗组合物及其制备方法 | |
| EP3601580A1 (en) | Norovirus fusion proteins and vlps comprising norovirus fusion proteins | |
| CA3133030C (en) | Norovirus-like particles with improved stability | |
| Tyulkina et al. | New viral vector for superproduction of epitopes of vaccine proteins in plants | |
| JP7429684B6 (ja) | 改変ノロウイルスｖｐ１タンパク質および改変ノロウイルスｖｐ１タンパク質を含むｖｌｐ | |
| CN121758570A (zh) | 非洲猪瘟病毒CD2v蛋白的免疫原性组合物及其应用 | |
| CN114685676B (zh) | 一种重组蛋白及其表达方法、纯化方法及用途 | |
| CN121758566A (zh) | 非洲猪瘟病毒e248r蛋白的免疫原性组合物及其应用 | |
| CN105085625A (zh) | 一种兼抗肠道病毒71和柯萨奇病毒a16的基因工程疫苗 | |
| US12467058B2 (en) | Influenza virus-like particle production in plants | |
| Ogriņa | Molecular Solutions for Plant Virus-Like Particles Based Vaccine Generation | |
| WO2025093037A1 (zh) | 非洲猪瘟病毒p54蛋白的免疫原性组合物及其应用 | |
| Choi et al. | Expression of rotavirus capsid proteins VP6 and VP7 in mammalian cells using semliki forest virus-based expression system | |
| Di Franco et al. | Partial characterization of Artichoke virus M | |
| BR102018011834A2 (pt) | polipeptídeo flaviviral com finalidade vacinal e diagnostica produzido em planta | |
| TW201713680A (zh) | 嵌合型竹嵌紋病毒蛋白質與粒子、使用嵌合型竹嵌紋病毒載體而從衍生自基因轉殖植物的懸浮細胞中生產它們的方法，以及它們的應用 |